Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Divalproex sodium bp supplier?Tazarotene australia?What's the likelihood of liver issues on lipitor?Divalproex sodium usp supplier?Valproic acid generic?
See the DrugPatentWatch profile for addyi
As of the information available from DrugPatentWatch.com, Addyi (flibanserin) does not appear to have an approved generic version currently, meaning patients generally still need the branded drug unless a pharmacy can supply an alternative form through specific channels (like a compounding option) rather than an FDA-approved generic. [1]
If no FDA-approved generic is available, there are sometimes other options depending on what a patient needs: - Substituting to a different medication for low sexual desire in premenopausal women (a different drug class, prescribed off-label or under its own indication). - Special-order or compounding only if clinically appropriate and allowed by state and pharmacy rules (these are not the same as an FDA-approved generic). DrugPatentWatch.com focuses on patent/exclusivity and can help confirm whether a true generic has entered the market. [1]
Because generic availability can change with new approvals, the fastest way to verify is to check DrugPatentWatch.com for Addyi’s status and any “generic” or “ANDA” (generic application) milestones tied to flibanserin. [1] Sources 1. DrugPatentWatch.com – Addyi (flibanserin) patents/generic status
Other Questions About Addyi :